CHAMPIONS ONCOLOGY, INC. Public Float
CHAMPIONS ONCOLOGY, INC. (CSBR) had Public Float of $28.60 million as of 2025-10-31, per its 10-K filed 2026-07-27.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-07-27
- 2025-10-31: Entity Public Float $28.60M.
- 2024-10-31: Entity Public Float $15.40M.
- 2023-10-31: Entity Public Float $22.00M.
- 2022-10-31: Entity Public Float $28.00M.
| Period end | Entity Public Float |
|---|---|
| 2025-10-31 | $28.60M 10-K · filed 2026-07-27 |
| 2024-10-31 | $15.40M 10-K · filed 2025-07-23 |
| 2023-10-31 | $22.00M 10-K · filed 2024-07-19 |
| 2022-10-31 | $28.00M 10-K · filed 2023-07-24 |
| 2021-10-31 | $44.00M 10-K · filed 2022-07-22 |
| 2020-10-31 | $50.10M 10-K · filed 2021-07-26 |
| 2019-10-31 | $31.00M 10-K · filed 2020-07-28 |
| 2018-10-31 | $72.50M 10-K · filed 2019-07-29 |
| 2017-10-31 | $17.30M 10-K · filed 2018-07-30 |
| 2016-10-31 | $17.30M 10-K · filed 2017-07-28 |
| 2015-10-31 | $47.50M 10-K · filed 2016-07-29 |
| 2014-10-31 | $30.00M 10-K · filed 2015-07-29 |
| 2012-10-31 | $30.00M 10-K · filed 2014-07-28 |
| 2011-10-31 | $18.70M 10-K · filed 2012-07-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |